1,378
Views
0
CrossRef citations to date
0
Altmetric
Research Article

A noninvasive method for the detection of foetal DNA in early pregnancy based on differential methylation pattern of Ras association domain family member 1A

, , , , &
Article: 2292611 | Received 21 Jul 2023, Accepted 04 Dec 2023, Published online: 10 Jan 2024

References

  • Adinolfi, M., et al., 1995. Molecular evidence of fetal-derived chromosome 21 markers (STRs) in transcervical samples. Prenatal Diagnosis, 15 (1), 35–39.
  • Apps, R., Gardner, L. and Moffett, A., 2008. A critical look at HLA-G. Trends in Immunology, 29 (7), 313–321.
  • Arutyunyan, A., et al., 2023. Spatial multiomics map of trophoblast development in early pregnancy. Nature, 616 (7955), 143–151.
  • Bianchi, D.W., et al., 2015. Noninvasive prenatal testing and incidental detection of occult maternal malignancies. JAMA, 314 (2), 162–169.
  • Bolnick, J.M., et al., 2014. Trophoblast retrieval and isolation from the cervix (TRIC) for noninvasive prenatal screening at 5 to 20 weeks of gestation. Fertility and Sterility, 102 (1), 135–142 e136.
  • Bulmer, J.N., et al., 2023. HLA-G positive trophoblastic cells in transcervical samples and their isolation and analysis by laser microdissection and QF-PCR. Prenatal Diagnosis, 23 (1), 34–39.
  • Bulmer, J.N., Rodeck, C. and Adinolfi, M., 1995. Immunohistochemical characterization of cells retrieved by transcervical sampling in early pregnancy. Prenatal Diagnosis, 15 (12), 1143–1153.
  • Chan, K.C., et al., 2006. Hypermethylated RASSF1A in maternal plasma: a universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis. Clinical Chemistry, 52 (12), 2211–2218.
  • Chiu, R.W. K., et al., 2007. Hypermethylation of RASSF1A in human and rhesus placentas. The American Journal of Pathology, 170 (3), 941–950.
  • Cioni, R., et al., 2005. Comparison of two techniques for transcervical cell sampling performed in the same study population. Prenatal Diagnosis, 25 (3), 198–202.
  • ErgIn, T., et al., 2001. Non-invasive early prenatal diagnosis using fuorescent in situ hybridization on transcervical cells: comparison of two different methods for retrieval. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 95 (1), 37–41.
  • Fritz, R., et al., 2015. Trophoblast retrieval and isolation from the cervix (TRIC) is unaffected by early gestational age or maternal obesity. Prenatal Diagnosis, 35 (12), 1218–1222.
  • García-Gutiérrez, L., et al., 2020. D. RASSF1A tumour suppressor: target the network for effective cancer therapy. Cancers, 12 (1), 229.
  • Griffith-Jones, M. D., et al., 1992. Detection of fetal DNA in trans-cervical swabs from first trimester pregnancies by gene amplification: a new route to prenatal diagnosis? British Journal of Obstetrics and Gynaecology, 99 (6), 508–511.
  • Hong, K., et al., 2022. Advanced strategy of trophoblasts retrieval and isolation from the cervix (TRIC): comparison of two HLA-G antibodies for immunomagnetic isolation of trophoblasts. Journal of Personalized Medicine, 13 (1), 22.
  • Hromadnikova, I., et al., 2010. Quantification of extracellular DNA using hypermethylated RASSF1A, SRY, and GLO sequences—evaluation of diagnostic possibilities for predicting placental insufficiency. DNA and Cell Biology, 29 (6), 295–301.
  • Kliman, H.J., et al., 1986. Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae. Endocrinology, 118 (4), 1567–1582.
  • Lee, C.Q., et al., 2016. What is trophoblast? A combination of criteria define human first-trimester trophoblast. Stem Cell Reports, 6 (2), 257–272.
  • Lo, Y.M., et al., 1998. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. American Journal of Human Genetics, 62 (4), 768–775.
  • Mantzaris, D. and Cram, D.S., 2015. Potential of syncytiotrophoblasts isolated from the cervical mucus for early non-invasive prenatal diagnosis: evidence of a vanishing twin. Clinica Chimica Acta; International Journal of Clinical Chemistry, 438, 309–315.
  • Massari, A., et al., 1996. Non-invasive early prenatal molecular diagnosis using retrieved transcervical trophoblast cells. Human Genetics, 97 (2), 150–155.
  • Moser, G., et al., 2010. Endoglandular trophoblast, an alternative route of trophoblast invasion? Analysis with novel confrontation co-culture models. Human Reproduction (Oxford, England), 25 (5), 1127–1136.
  • Moser, G., et al., 2018. Trophoblast retrieval and isolation from the cervix: origins of cervical trophoblasts and their potential value for risk assessment of ongoing pregnancies. Human Reproduction Update, 24 (4), 484–496.
  • Pan, J., et al., 2013. Association between RASSF1A promoter methylation and prostate cancer: a systematic review and meta-analysis. PLoS One, 8 (9), e75283.
  • Saraswathy, S., et al., 2017. Fetal-specific hypermethylated RASSF1A quantification in pregnancy. The Journal of Maternal-Fetal & Neonatal Medicine, 30 (7), 849–853.
  • Song, M.S., et al., 2004. The tumour suppressor RASSF1A regulates mitosis by inhibiting the APC-Cdc20 complex. Nature Cell Biology, 6 (2), 129–137.
  • Steele, M.W. and Breg, W.R., 1966. Chromosome analysis of human amniotic-fluid cells. Lancet (London, England), 1 (7434), 383–385.
  • Stranc, L.C., Evans, J.A. and Hamerton, J.L., 1997. Chorionic villus sampling and amniocentesis for prenatal diagnosis. Lancet (London, England), 349 (9053), 711–714.
  • Wide, M., et al., 1988. Localization of mRNA for the β-subunit of placental hCG by in situ hybridization. Acta Endocrinologica, 119 (1), 69–74.